首页 | 本学科首页   官方微博 | 高级检索  
     

立体定向放疗用于结直肠癌肝与肺寡转移的研究进展
引用本文:雷俊琴,刘文扬,金晶. 立体定向放疗用于结直肠癌肝与肺寡转移的研究进展[J]. 中华放射肿瘤学杂志, 2021, 30(12): 1316-1320. DOI: 10.3760/cma.j.cn113030-20200330-00145
作者姓名:雷俊琴  刘文扬  金晶
作者单位:国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科 100021;国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院深圳医院放疗科 518116
摘    要:寡转移是肿瘤从局部区域病变进展到远处广泛转移过程中存在的一种中间状态,通过局部治疗有获得长期生存的可能。体部立体定向放疗(SBRT)单次剂量高、分割次数少,是一种高精准的局部消融治疗手段。结直肠癌有近一半患者会发生转移,主要转移部位为肝和肺。本文主要阐述SBRT治疗结直肠癌肝、肺寡转移灶的安全性、近期疗效及其影响因素,同时也总结了SBRT具体实施的要点。SBRT在严格的呼吸运动管理和放疗质控下是治疗结直肠癌寡转移的有效手段。

关 键 词:肿瘤/寡转移  结直肠癌  肝转移/立体定向放射疗法  结直肠癌  肺转移/立体定向放射疗法  研究进展  
收稿时间:2020-03-30

Stereotactic body radiation therapy for liver and lung oligometastases from colorectal cancer:safety,local efficacy and prognostic factors
Lei Junqin,Liu Wenyang,Jin Jing. Stereotactic body radiation therapy for liver and lung oligometastases from colorectal cancer:safety,local efficacy and prognostic factors[J]. Chinese Journal of Radiation Oncology, 2021, 30(12): 1316-1320. DOI: 10.3760/cma.j.cn113030-20200330-00145
Authors:Lei Junqin  Liu Wenyang  Jin Jing
Affiliation:Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital&Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China
Abstract:Oligometastasis is an intermediate status between the locally advanced andwide spread disease. Patients with oligometastasis may obtain long-term survival after local treatment. Stereotactic body radiation therapy (SBRT) can deliver radical ablative doses in a small number of fractions, which is a highly precise local ablation therapy. Approximately half of patients diagnosed with colorectal cancer (CRC) will develop metastases, with the liver and lung as the most common site of involvement. In this article, the safety, local efficacy and prognostic factors of SBRT for liver and lung oligometastases from CRC were illustrated. The highlights of SBRT implementation were also discussed. SBRT is safe and effective for oligometastases from CRC under respiratory motion management and robust quality assurance.
Keywords:Neoplasm/oligometastasis  Colorectal cancer   liver metastasis/stereotactic body radiation therapy  Colorectal cancer   lung metastasis/Stereotactic body radiation therapy  Research progress  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号